शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
PIINDNSEPI Industries Limited· Fertilizers & AgrochemicalsHighPositive
Announced Thu, 12 Feb, 2026 · 19:04 IST

PI Industries Limited has informed the Exchange that Record date for the purpose of Interim Dividend is 23-Feb-2026.

PIIND · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+0.1%Reaction day
₹3163.70
prior close
₹3035.00
announcement price
After-mkt
timing
Nifty Midcap 150market · index membership as recorded later (tracked since Jun 2026)-1.7%+1.8% vs market
Pesticides & Agrochemicals peers, median of 27sector-1.6%+1.7% vs sector

On the reaction day the stock moved 1.8 pts more than Nifty Midcap 150 and 1.7 pts more than its Pesticides & Agrochemicals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+3.4
10m
+2.2
15m
+2.3
30m
+2.5
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+0.1-1.7+1.8-1.6+1.7
Next day
-3.6-1.2-2.4-2.9-0.7
2d
-2.5-1.0-1.6-1.9-0.6
3d
-4.4-0.4-4.0-2.0-2.5
4d
-4.5-2.0-2.6-3.8-0.7
5d
-3.6-1.5-2.1-3.9+0.4
1w
-1.8-1.9+0.2-7.2+5.4
15d
-4.2-6.8+2.6-12.1+7.9
1m
-8.3-9.1+0.7-14.7+6.4
2m
-7.8-4.8-3.0-9.8+2.0
3m
-3.6-0.7-2.9-3.9+0.4
UpDownMarket · Nifty Midcap 150Sector · Pesticides & Agrochemicals peers, median of 27Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

PI Industries' board, at its February 12, 2026 meeting, approved the unaudited Q3 FY26 results and declared an interim dividend of Rs. 5 per share (500%) on equity shares of Re. 1 face value, payable by March 13, 2026. The record date is February 23, 2026. Standalone Q3 revenue fell to Rs. 12,696 Mn (vs Rs. 17,798 Mn in Q3 FY25) and standalone profit dropped to Rs. 2,816 Mn (vs Rs. 4,238 Mn YoY), with 9M FY26 standalone profit at Rs. 12,370 Mn vs Rs. 14,807 Mn last year. On a consolidated basis, Q3 revenue was Rs. 13,757 Mn and profit was Rs. 3,113 Mn, boosted by an exceptional gain of Rs. 1,051 Mn (mainly a Rs. 1,260 Mn write-back of contingent consideration on the PI Health Sciences acquisition), partially offset by a Rs. 209 Mn one-time Labour Codes liability.

Likely market impact

Sharply lower sequential and YoY standalone profits signal weak operating performance, which may weigh on the stock. However, the interim dividend rewards shareholders, and the consolidated exceptional gain from the pharma acquisition write-back provides a cushion to earnings.